Morphic Therapeutic, Inc. logo

Morphic Therapeutic, Inc.

Morphic Therapeutic is leading the development of a new generation of oral integrin drugs. Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma. New investors SROne, Pfizer Ventures, Omega Funds and AbbVie joined for the Series A round in June 2016.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://morphictx.com
Disease Focus
STOCK CODENon Listed
Address
35 Gatehouse Drive, A2, MA 02451
Waltham
United States
Email
Contact Number
+1 781-996-0955

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/morphic-therapeutic” connections=”true” suffix=””]